APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atomoxetine Hydrochloride Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Research

Atomoxetine Hydrochloride Capsules Industry Research Report 2026

28 December 2025126 pages

Choose your research edition.

Industry ResearchAtomoxetine Hydrochloride Capsules Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Atomoxetine Hydrochloride Capsules Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Atomoxetine Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atomoxetine Hydrochloride Capsules Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Atomoxetine Hydrochloride Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Atomoxetine Hydrochloride Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Atomoxetine Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Atomoxetine Hydrochloride Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Atomoxetine Hydrochloride Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Atomoxetine Hydrochloride Capsules include Zhejiang Huahai Pharmaceutical, Shandong Loncom Pharmaceutical, Eli Lilly, Jiangsu Chia Tai Fenghai Pharmaceutical, Jiangsu Yongan Pharmaceutical, Zydus, Teva, Sun Pharma and Strides Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Atomoxetine Hydrochloride Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Atomoxetine Hydrochloride Capsules Market by Company

Zhejiang Huahai Pharmaceutical

Shandong Loncom Pharmaceutical

Eli Lilly

Jiangsu Chia Tai Fenghai Pharmaceutical

Jiangsu Yongan Pharmaceutical

Zydus

Teva

Sun Pharma

Strides Pharma

Hetero

Glenmark

Dr. Reddy's Laboratories

Aurobindo Pharma

Apotex

Atomoxetine Hydrochloride Capsules Segment by Type

10mg per Unit

18mg per Unit

25mg per Unit

40mg per Unit

60mg per Unit

80mg per Unit

100mg per Unit

Atomoxetine Hydrochloride Capsules Segment by Application

Hospital and Clinic

Pharmacy

Other

Atomoxetine Hydrochloride Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atomoxetine Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atomoxetine Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atomoxetine Hydrochloride Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Atomoxetine Hydrochloride Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Atomoxetine Hydrochloride Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Atomoxetine Hydrochloride Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Atomoxetine Hydrochloride Capsules Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Atomoxetine Hydrochloride Capsules Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Manufacturers (2021-2026) Table 8. Global Atomoxetine Hydrochloride Capsules Revenue of Manufacturers (2021-2026) Table 9. Global Atomoxetine Hydrochloride Capsules Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Atomoxetine Hydrochloride Capsules Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Atomoxetine Hydrochloride Capsules Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Atomoxetine Hydrochloride Capsules, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Atomoxetine Hydrochloride Capsules, Product Type & Application Table 14. Global Atomoxetine Hydrochloride Capsules Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Atomoxetine Hydrochloride Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang Huahai Pharmaceutical Company Information Table 19. Zhejiang Huahai Pharmaceutical Business Overview Table 20. Zhejiang Huahai Pharmaceutical Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhejiang Huahai Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio Table 22. Zhejiang Huahai Pharmaceutical Recent Developments Table 23. Shandong Loncom Pharmaceutical Company Information Table 24. Shandong Loncom Pharmaceutical Business Overview Table 25. Shandong Loncom Pharmaceutical Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Shandong Loncom Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio Table 27. Shandong Loncom Pharmaceutical Recent Developments Table 28. Eli Lilly Company Information Table 29. Eli Lilly Business Overview Table 30. Eli Lilly Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Eli Lilly Atomoxetine Hydrochloride Capsules Product Portfolio Table 32. Eli Lilly Recent Developments Table 33. Jiangsu Chia Tai Fenghai Pharmaceutical Company Information Table 34. Jiangsu Chia Tai Fenghai Pharmaceutical Business Overview Table 35. Jiangsu Chia Tai Fenghai Pharmaceutical Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Jiangsu Chia Tai Fenghai Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio Table 37. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments Table 38. Jiangsu Yongan Pharmaceutical Company Information Table 39. Jiangsu Yongan Pharmaceutical Business Overview Table 40. Jiangsu Yongan Pharmaceutical Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Jiangsu Yongan Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio Table 42. Jiangsu Yongan Pharmaceutical Recent Developments Table 43. Zydus Company Information Table 44. Zydus Business Overview Table 45. Zydus Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Zydus Atomoxetine Hydrochloride Capsules Product Portfolio Table 47. Zydus Recent Developments Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Teva Atomoxetine Hydrochloride Capsules Product Portfolio Table 52. Teva Recent Developments Table 53. Sun Pharma Company Information Table 54. Sun Pharma Business Overview Table 55. Sun Pharma Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sun Pharma Atomoxetine Hydrochloride Capsules Product Portfolio Table 57. Sun Pharma Recent Developments Table 58. Strides Pharma Company Information Table 59. Strides Pharma Business Overview Table 60. Strides Pharma Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Strides Pharma Atomoxetine Hydrochloride Capsules Product Portfolio Table 62. Strides Pharma Recent Developments Table 63. Hetero Company Information Table 64. Hetero Business Overview Table 65. Hetero Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Hetero Atomoxetine Hydrochloride Capsules Product Portfolio Table 67. Hetero Recent Developments Table 68. Glenmark Company Information Table 69. Glenmark Business Overview Table 70. Glenmark Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Glenmark Atomoxetine Hydrochloride Capsules Product Portfolio Table 72. Glenmark Recent Developments Table 73. Dr. Reddy's Laboratories Company Information Table 74. Dr. Reddy's Laboratories Business Overview Table 75. Dr. Reddy's Laboratories Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Dr. Reddy's Laboratories Atomoxetine Hydrochloride Capsules Product Portfolio Table 77. Dr. Reddy's Laboratories Recent Developments Table 78. Aurobindo Pharma Company Information Table 79. Aurobindo Pharma Business Overview Table 80. Aurobindo Pharma Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Aurobindo Pharma Atomoxetine Hydrochloride Capsules Product Portfolio Table 82. Aurobindo Pharma Recent Developments Table 83. Apotex Company Information Table 84. Apotex Business Overview Table 85. Apotex Atomoxetine Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Apotex Atomoxetine Hydrochloride Capsules Product Portfolio Table 87. Apotex Recent Developments Table 88. Global Atomoxetine Hydrochloride Capsules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Atomoxetine Hydrochloride Capsules Sales by Region (2021-2026) & (K Units) Table 90. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Region (2021-2026) Table 91. Global Atomoxetine Hydrochloride Capsules Sales by Region (2027-2032) & (K Units) Table 92. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Region (2027-2032) Table 93. Global Atomoxetine Hydrochloride Capsules Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Region (2021-2026) Table 95. Global Atomoxetine Hydrochloride Capsules Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Region (2027-2032) Table 97. North America Atomoxetine Hydrochloride Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Atomoxetine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 99. North America Atomoxetine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 100. North America Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Atomoxetine Hydrochloride Capsules Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Atomoxetine Hydrochloride Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Atomoxetine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 104. Europe Atomoxetine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 105. Europe Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Atomoxetine Hydrochloride Capsules Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Atomoxetine Hydrochloride Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Atomoxetine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Atomoxetine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Atomoxetine Hydrochloride Capsules Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Atomoxetine Hydrochloride Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Atomoxetine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 114. South America Atomoxetine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 115. South America Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Atomoxetine Hydrochloride Capsules Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Atomoxetine Hydrochloride Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Atomoxetine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Atomoxetine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Atomoxetine Hydrochloride Capsules Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Atomoxetine Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 123. Global Atomoxetine Hydrochloride Capsules Sales by Type (2027-2032) & (K Units) Table 124. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Type (2021-2026) Table 125. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Type (2027-2032) Table 126. Global Atomoxetine Hydrochloride Capsules Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Atomoxetine Hydrochloride Capsules Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Type (2021-2026) Table 129. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Type (2027-2032) Table 130. Global Atomoxetine Hydrochloride Capsules Price by Type (2021-2026) & (US$/Unit) Table 131. Global Atomoxetine Hydrochloride Capsules Price by Type (2027-2032) & (US$/Unit) Table 132. Global Atomoxetine Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 133. Global Atomoxetine Hydrochloride Capsules Sales by Application (2027-2032) & (K Units) Table 134. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Application (2021-2026) Table 135. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Application (2027-2032) Table 136. Global Atomoxetine Hydrochloride Capsules Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Atomoxetine Hydrochloride Capsules Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Application (2021-2026) Table 139. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Application (2027-2032) Table 140. Global Atomoxetine Hydrochloride Capsules Price by Application (2021-2026) & (US$/Unit) Table 141. Global Atomoxetine Hydrochloride Capsules Price by Application (2027-2032) & (US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Atomoxetine Hydrochloride Capsules Distributors List Table 145. Atomoxetine Hydrochloride Capsules Customers List Table 146. Atomoxetine Hydrochloride Capsules Industry Trends Table 147. Atomoxetine Hydrochloride Capsules Industry Drivers Table 148. Atomoxetine Hydrochloride Capsules Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Atomoxetine Hydrochloride Capsules Product Image Figure 5. Global Atomoxetine Hydrochloride Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Atomoxetine Hydrochloride Capsules Market Size (2021-2032) & (US$ Million) Figure 7. Global Atomoxetine Hydrochloride Capsules Sales (2021-2032) & (K Units) Figure 8. Global Atomoxetine Hydrochloride Capsules Average Price (US$/Unit) & (2021-2032) Figure 9. 10mg per Unit Product Image Figure 10. 18mg per Unit Product Image Figure 11. 25mg per Unit Product Image Figure 12. 40mg per Unit Product Image Figure 13. 60mg per Unit Product Image Figure 14. 80mg per Unit Product Image Figure 15. 100mg per Unit Product Image Figure 16. Hospital and Clinic Product Image Figure 17. Pharmacy Product Image Figure 18. Other Product Image Figure 19. Global Atomoxetine Hydrochloride Capsules Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Atomoxetine Hydrochloride Capsules, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Atomoxetine Hydrochloride Capsules Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Atomoxetine Hydrochloride Capsules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Atomoxetine Hydrochloride Capsules Sales by Region in 2025 Figure 25. Global Atomoxetine Hydrochloride Capsules Revenue by Region in 2025 Figure 26. North America Atomoxetine Hydrochloride Capsules Market Size by Country in 2025 Figure 27. North America Atomoxetine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 28. North America Atomoxetine Hydrochloride Capsules Revenue Market Share by Country (2021-2032) Figure 29. United States Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Atomoxetine Hydrochloride Capsules Market Size by Country in 2025 Figure 33. Europe Atomoxetine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 34. Europe Atomoxetine Hydrochloride Capsules Revenue Market Share by Country (2021-2032) Figure 35. Germany Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Atomoxetine Hydrochloride Capsules Market Size by Country in 2025 Figure 46. Asia Pacific Atomoxetine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Atomoxetine Hydrochloride Capsules Revenue Market Share by Country (2021-2032) Figure 48. China Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Atomoxetine Hydrochloride Capsules Market Size by Country in 2025 Figure 57. South America Atomoxetine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 58. South America Atomoxetine Hydrochloride Capsules Revenue Market Share by Country (2021-2032) Figure 59. Brazil Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Colombia Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Atomoxetine Hydrochloride Capsules Market Size by Country in 2025 Figure 64. Middle East and Africa Atomoxetine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Atomoxetine Hydrochloride Capsules Revenue Market Share by Country (2021-2032) Figure 66. Egypt Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Atomoxetine Hydrochloride Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Type (2021-2032) Figure 72. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Type (2021-2032) Figure 73. Global Atomoxetine Hydrochloride Capsules Price (US$/Unit) by Type (2021-2032) Figure 74. Global Atomoxetine Hydrochloride Capsules Sales Market Share by Application (2021-2032) Figure 75. Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Application (2021-2032) Figure 76. Global Atomoxetine Hydrochloride Capsules Price (US$/Unit) by Application (2021-2032) Figure 77. Atomoxetine Hydrochloride Capsules Value Chain Figure 78. Atomoxetine Hydrochloride Capsules Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Atomoxetine Hydrochloride Capsules Industry Opportunities and Challenges

Scope & coverage.

Types
  • 10mg per Unit
  • 18mg per Unit
  • 25mg per Unit
  • 40mg per Unit
  • 60mg per Unit
  • 80mg per Unit
  • 100mg per Unit
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Shandong Loncom Pharmaceutical
  • Eli Lilly
  • Jiangsu Chia Tai Fenghai Pharmaceutical
  • Jiangsu Yongan Pharmaceutical
  • Zydus
  • Teva
  • Sun Pharma
  • Strides Pharma
  • Hetero
  • Glenmark
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma
  • Apotex

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Atomoxetine Hydrochloride Capsules Market Size (2021-2032)
  4. 2.2.2 Global Atomoxetine Hydrochloride Capsules Sales (2021-2032)
  5. 2.2.3 Global Atomoxetine Hydrochloride Capsules Market Average Price (2021-2032)
  6. 2.3 Atomoxetine Hydrochloride Capsules by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 10mg per Unit
  9. 2.3.3 18mg per Unit
  10. 2.3.4 25mg per Unit
  11. 2.3.5 40mg per Unit
  12. 2.3.6 60mg per Unit
  13. 2.3.7 80mg per Unit
  14. 2.3.8 100mg per Unit
  15. 2.4 Atomoxetine Hydrochloride Capsules by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Hospital and Clinic
  18. 2.4.3 Pharmacy
  19. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Atomoxetine Hydrochloride Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Atomoxetine Hydrochloride Capsules Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Atomoxetine Hydrochloride Capsules Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Atomoxetine Hydrochloride Capsules Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Atomoxetine Hydrochloride Capsules Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Atomoxetine Hydrochloride Capsules, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Atomoxetine Hydrochloride Capsules, Product Type & Application
  8. 3.8 Global Manufacturers of Atomoxetine Hydrochloride Capsules, Established Date
  9. 3.9 Global Atomoxetine Hydrochloride Capsules Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Huahai Pharmaceutical
  2. 4.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 4.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 4.1.3 Zhejiang Huahai Pharmaceutical Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Huahai Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio
  6. 4.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 4.2 Shandong Loncom Pharmaceutical
  8. 4.2.1 Shandong Loncom Pharmaceutical Company Information
  9. 4.2.2 Shandong Loncom Pharmaceutical Business Overview
  10. 4.2.3 Shandong Loncom Pharmaceutical Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shandong Loncom Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio
  12. 4.2.5 Shandong Loncom Pharmaceutical Recent Developments
  13. 4.3 Eli Lilly
  14. 4.3.1 Eli Lilly Company Information
  15. 4.3.2 Eli Lilly Business Overview
  16. 4.3.3 Eli Lilly Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Eli Lilly Atomoxetine Hydrochloride Capsules Product Portfolio
  18. 4.3.5 Eli Lilly Recent Developments
  19. 4.4 Jiangsu Chia Tai Fenghai Pharmaceutical
  20. 4.4.1 Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
  21. 4.4.2 Jiangsu Chia Tai Fenghai Pharmaceutical Business Overview
  22. 4.4.3 Jiangsu Chia Tai Fenghai Pharmaceutical Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Jiangsu Chia Tai Fenghai Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio
  24. 4.4.5 Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments
  25. 4.5 Jiangsu Yongan Pharmaceutical
  26. 4.5.1 Jiangsu Yongan Pharmaceutical Company Information
  27. 4.5.2 Jiangsu Yongan Pharmaceutical Business Overview
  28. 4.5.3 Jiangsu Yongan Pharmaceutical Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Jiangsu Yongan Pharmaceutical Atomoxetine Hydrochloride Capsules Product Portfolio
  30. 4.5.5 Jiangsu Yongan Pharmaceutical Recent Developments
  31. 4.6 Zydus
  32. 4.6.1 Zydus Company Information
  33. 4.6.2 Zydus Business Overview
  34. 4.6.3 Zydus Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Zydus Atomoxetine Hydrochloride Capsules Product Portfolio
  36. 4.6.5 Zydus Recent Developments
  37. 4.7 Teva
  38. 4.7.1 Teva Company Information
  39. 4.7.2 Teva Business Overview
  40. 4.7.3 Teva Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Teva Atomoxetine Hydrochloride Capsules Product Portfolio
  42. 4.7.5 Teva Recent Developments
  43. 4.8 Sun Pharma
  44. 4.8.1 Sun Pharma Company Information
  45. 4.8.2 Sun Pharma Business Overview
  46. 4.8.3 Sun Pharma Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sun Pharma Atomoxetine Hydrochloride Capsules Product Portfolio
  48. 4.8.5 Sun Pharma Recent Developments
  49. 4.9 Strides Pharma
  50. 4.9.1 Strides Pharma Company Information
  51. 4.9.2 Strides Pharma Business Overview
  52. 4.9.3 Strides Pharma Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Strides Pharma Atomoxetine Hydrochloride Capsules Product Portfolio
  54. 4.9.5 Strides Pharma Recent Developments
  55. 4.10 Hetero
  56. 4.10.1 Hetero Company Information
  57. 4.10.2 Hetero Business Overview
  58. 4.10.3 Hetero Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hetero Atomoxetine Hydrochloride Capsules Product Portfolio
  60. 4.10.5 Hetero Recent Developments
  61. 4.11 Glenmark
  62. 4.11.1 Glenmark Company Information
  63. 4.11.2 Glenmark Business Overview
  64. 4.11.3 Glenmark Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Glenmark Atomoxetine Hydrochloride Capsules Product Portfolio
  66. 4.11.5 Glenmark Recent Developments
  67. 4.12 Dr. Reddy's Laboratories
  68. 4.12.1 Dr. Reddy's Laboratories Company Information
  69. 4.12.2 Dr. Reddy's Laboratories Business Overview
  70. 4.12.3 Dr. Reddy's Laboratories Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dr. Reddy's Laboratories Atomoxetine Hydrochloride Capsules Product Portfolio
  72. 4.12.5 Dr. Reddy's Laboratories Recent Developments
  73. 4.13 Aurobindo Pharma
  74. 4.13.1 Aurobindo Pharma Company Information
  75. 4.13.2 Aurobindo Pharma Business Overview
  76. 4.13.3 Aurobindo Pharma Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Aurobindo Pharma Atomoxetine Hydrochloride Capsules Product Portfolio
  78. 4.13.5 Aurobindo Pharma Recent Developments
  79. 4.14 Apotex
  80. 4.14.1 Apotex Company Information
  81. 4.14.2 Apotex Business Overview
  82. 4.14.3 Apotex Atomoxetine Hydrochloride Capsules Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Apotex Atomoxetine Hydrochloride Capsules Product Portfolio
  84. 4.14.5 Apotex Recent Developments
5 Global Atomoxetine Hydrochloride Capsules Market Scenario by Region
  1. 5.1 Global Atomoxetine Hydrochloride Capsules Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Atomoxetine Hydrochloride Capsules Sales by Region: 2021-2032
  3. 5.2.1 Global Atomoxetine Hydrochloride Capsules Sales by Region: 2021-2026
  4. 5.2.2 Global Atomoxetine Hydrochloride Capsules Sales by Region: 2027-2032
  5. 5.3 Global Atomoxetine Hydrochloride Capsules Revenue by Region: 2021-2032
  6. 5.3.1 Global Atomoxetine Hydrochloride Capsules Revenue by Region: 2021-2026
  7. 5.3.2 Global Atomoxetine Hydrochloride Capsules Revenue by Region: 2027-2032
  8. 5.4 North America Atomoxetine Hydrochloride Capsules Market Facts & Figures by Country
  9. 5.4.1 North America Atomoxetine Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Atomoxetine Hydrochloride Capsules Sales by Country (2021-2032)
  11. 5.4.3 North America Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Atomoxetine Hydrochloride Capsules Market Facts & Figures by Country
  16. 5.5.1 Europe Atomoxetine Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Atomoxetine Hydrochloride Capsules Sales by Country (2021-2032)
  18. 5.5.3 Europe Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Atomoxetine Hydrochloride Capsules Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Atomoxetine Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Atomoxetine Hydrochloride Capsules Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Atomoxetine Hydrochloride Capsules Market Facts & Figures by Country
  41. 5.7.1 South America Atomoxetine Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Atomoxetine Hydrochloride Capsules Sales by Country (2021-2032)
  43. 5.7.3 South America Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Atomoxetine Hydrochloride Capsules Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Atomoxetine Hydrochloride Capsules Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Atomoxetine Hydrochloride Capsules Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Atomoxetine Hydrochloride Capsules Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Atomoxetine Hydrochloride Capsules Sales by Type (2021-2032)
  2. 6.1.1 Global Atomoxetine Hydrochloride Capsules Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Atomoxetine Hydrochloride Capsules Sales Market Share by Type (2021-2032)
  4. 6.2 Global Atomoxetine Hydrochloride Capsules Revenue by Type (2021-2032)
  5. 6.2.1 Global Atomoxetine Hydrochloride Capsules Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Atomoxetine Hydrochloride Capsules Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Atomoxetine Hydrochloride Capsules Sales by Application (2021-2032)
  2. 7.1.1 Global Atomoxetine Hydrochloride Capsules Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Atomoxetine Hydrochloride Capsules Sales Market Share by Application (2021-2032)
  4. 7.2 Global Atomoxetine Hydrochloride Capsules Revenue by Application (2021-2032)
  5. 7.2.1 Global Atomoxetine Hydrochloride Capsules Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Atomoxetine Hydrochloride Capsules Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Atomoxetine Hydrochloride Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Atomoxetine Hydrochloride Capsules Value Chain Analysis
  2. 8.1.1 Atomoxetine Hydrochloride Capsules Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Atomoxetine Hydrochloride Capsules Production Mode & Process
  5. 8.2 Atomoxetine Hydrochloride Capsules Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Atomoxetine Hydrochloride Capsules Distributors
  8. 8.2.3 Atomoxetine Hydrochloride Capsules Customers
9 Global Atomoxetine Hydrochloride Capsules Analyzing Market Dynamics
  1. 9.1 Atomoxetine Hydrochloride Capsules Industry Trends
  2. 9.2 Atomoxetine Hydrochloride Capsules Industry Drivers
  3. 9.3 Atomoxetine Hydrochloride Capsules Industry Opportunities and Challenges
  4. 9.4 Atomoxetine Hydrochloride Capsules Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst